₹ 133200
₹105- ₹111
1200
₹89
-20
7 Feb 2025
Download11 Feb 2025
12 Feb 2025
Application Details
The Initial Public Offering (IPO) of Amwill Health Care Limited is scheduled to open on February 5, 2025, and will close on February 7, 2025. This book-built issue IPO will be listed on the BSE SME platform. The total issue size is 54,03,600 shares, aggregating up to ₹59.98 crore, comprising a fresh issue of 44,03,600 shares worth ₹48.88 crore and an offer for sale of 10,00,000 shares with a face value of ₹10 each, aggregating up to ₹11.10 crore.
The price band for the IPO is set between ₹105 and ₹111 per share, with a lot size of 1,200 shares. Retail investors can apply for a minimum of one lot, requiring an investment of ₹1,33,200, while High Net-Worth Individuals (HNIs) must apply for at least two lots, totalling 2,400 shares with an investment of ₹2,66,400.
The basis of allotment will be finalized on February 10, 2025, followed by the initiation of refunds and credit of shares to demat accounts on February 11, 2025. The company’s shares are expected to be listed on February 12, 2025. In terms of reservation, not more than 20% of the net issue is allocated to Qualified Institutional Buyers (QIBs), while at least 40% is reserved for retail investors and another 40% for Non-Institutional Investors (NIIs), including HNIs.
About Amwill Healthcare Limited (SME IPO)
Incorporated in August 2017, Amwill Health Care Limited is a derma-cosmetic development firm that collaborates with contract manufacturers, distributors, and third-party product development agencies to enhance its manufacturing, packaging, and distribution capabilities. The company's product portfolio is categorized into two segments: the development of generic dermatological solutions and the formulation of targeted solutions for specific dermatological issues.
Amwill Health Care markets its products primarily in Karnataka, Andhra Pradesh, and Telangana, focusing on strengthening its presence in these regions before expanding into new markets to build a solid customer base. The company develops products to address various dermatological disorders, including acne, fungal infections, anti-aging concerns, histaminic reactions, periorbital hyperpigmentation, scabies, excessive perspiration, trichology-related issues, and vitiligo.
FAQ
IPO stands for "Initial Public Offering." It's the process through which a privately-held company becomes publicly traded by offering its shares to the general public and listing them on a stock exchange for trading. This allows the company to raise capital from investors and grants individuals and institutions the opportunity to invest in and own a portion of the company.
The life cycle of an IPO, or Initial Public Offering, begins with a company's decision to go public. It involves hiring underwriters, registering with regulatory authorities, determining the IPO price, marketing to investors, and the subscription period where investors place orders for shares. After allocation and listing, shares become publicly tradable, and the company enters the secondary market. Ongoing reporting and corporate governance are crucial as the company continues to operate as a publicly-traded entity. The IPO aims to raise capital for growth and provides investors with opportunities to trade shares in the company.
An IPO (Initial Public Offering) is when a private company goes public by selling shares to the public. Investors buy these shares, giving them ownership in the company. It's a way for companies to raise capital and expand. The process involves underwriters, regulatory filings, setting the IPO price, and marketing to investors. After the IPO, shares can be traded on a stock exchange. IPOs offer opportunities and risks, so investors should research and consider carefully.
"Upcoming IPOs" refers to initial public offerings that have been announced by private companies but have not yet occurred. These are companies that plan to go public in the near future by issuing shares to the public and listing them on a stock exchange. Investors often keep an eye on upcoming IPOs as they represent opportunities to invest in companies at their early stages of public trading, potentially capturing growth potential. These offerings are typically accompanied by significant media and investor attention as they approach their launch dates.